News

Bone Therapeutics raises €19.45M of commitments in convertible bond placement

This placing will support Bone Therapeutics in the development of its unique pipeline of cell therapy products. Congratulations ! For more information, please read March 7th 2018 publication in L'Echo.

Read more

Apaxen is looking for a CEO

Apaxen, a preclinical stage biotech developing first in class anti-inflammatory therapeutics with a primary focus on Pulmonary Arterial Hypertension is looking for a CEO to support its creation and development in Wallonia . Interested ? Please check the job offering and send your CV to contact@apaxen.com

Read more